Age related macular degeneration.
作者信息
Chopdar Amresh, Chakravarthy Usha, Verma Dinesh
机构信息
East Surrey Hospital, Redhill, Surrey RH1 5RH.
出版信息
BMJ. 2003 Mar 1;326(7387):485-8. doi: 10.1136/bmj.326.7387.485.
Abstract
摘要
相似文献
1
Age related macular degeneration.
BMJ. 2003 Mar 1;326(7387):485-8. doi: 10.1136/bmj.326.7387.485.
2
Age related macular degeneration.
BMJ. 2010 Feb 26;340:c981. doi: 10.1136/bmj.c981.
3
Age-Related Macular Degeneration.
Prim Care. 2015 Sep;42(3):377-91. doi: 10.1016/j.pop.2015.05.009.
4
Management of older people with dry and wet age-related macular degeneration.
Nurs Older People. 2010 Jun;22(5):21-6. doi: 10.7748/nop2010.06.22.5.21.c7793.
5
Wet age-related macular degeneration.
Nat Rev Drug Discov. 2005 Sep;4(9):711-2. doi: 10.1038/nrd1827.
6
Age-related macular degeneration.
Postgrad Med J. 1998 Apr;74(870):203-7. doi: 10.1136/pgmj.74.870.203.
7
Age-related macular degeneration.
Ulster Med J. 2005 Sep;74(2):82-92.
8
[New therapeutic aspects in age-related macular degeneration].
Med Clin (Barc). 2007 Nov 10;129(17):658-9. doi: 10.1157/13112103.
9
Recent advances in the treatment of age-related macular degeneration.
Br J Gen Pract. 2008 May;58(550):309-10. doi: 10.3399/096016408784217395.
10
Introduction to the issue regarding research regarding age related macular degeneration.
Mol Aspects Med. 2012 Aug;33(4):291-4. doi: 10.1016/j.mam.2012.04.002. Epub 2012 Apr 20.
引用本文的文献
1
Intraocular injectable hydrogels for the delivery of cells and nanoparticles.
Mater Today Bio. 2025 Apr 12;32:101767. doi: 10.1016/j.mtbio.2025.101767. eCollection 2025 Jun.
2
Age-Related Macular Degeneration: An Exponentially Emerging Imminent Threat of Visual Impairment and Irreversible Blindness.
Cureus. 2023 May 29;15(5):e39624. doi: 10.7759/cureus.39624. eCollection 2023 May.
3
Training With Simulated Scotoma Leads to Behavioral Improvements Through at Least Two Distinct Mechanisms.
Invest Ophthalmol Vis Sci. 2023 Jan 3;64(1):14. doi: 10.1167/iovs.64.1.14.
4
Impact of Primary RPE Cells in a Porcine Organotypic Co-Cultivation Model.
Biomolecules. 2022 Jul 16;12(7):990. doi: 10.3390/biom12070990.
5
Challenges in Age-Related Macular Degeneration: From Risk Factors to Novel Diagnostics and Prevention Strategies.
Front Med (Lausanne). 2022 Jun 6;9:887104. doi: 10.3389/fmed.2022.887104. eCollection 2022.
6
Ranibizumab port delivery system in neovascular age-related macular degeneration.
Ther Adv Ophthalmol. 2022 Feb 7;14:25158414211072623. doi: 10.1177/25158414211072623. eCollection 2022 Jan-Dec.
7
A Delphi study on the clinical management of age-related macular degeneration.
Int Ophthalmol. 2022 Jun;42(6):1799-1809. doi: 10.1007/s10792-021-02177-2. Epub 2022 Feb 12.
8
Preparation and Characterization of a Lutein Solid Dispersion to Improve Its Solubility and Stability.
AAPS PharmSciTech. 2021 Jun 2;22(5):169. doi: 10.1208/s12249-021-02036-4.
9
Incidence, individual, and macro level risk factors of severe binocular visual impairment and blindness in persons aged 50 and older.
PLoS One. 2021 May 3;16(5):e0251018. doi: 10.1371/journal.pone.0251018. eCollection 2021.
10
Utilizing Recombinant Spider Silk Proteins To Develop a Synthetic Bruch's Membrane for Modeling the Retinal Pigment Epithelium.
ACS Biomater Sci Eng. 2019 Aug 12;5(8):4023-4036. doi: 10.1021/acsbiomaterials.9b00183. Epub 2019 Jul 16.
本文引用的文献
1
Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.
Cochrane Database Syst Rev. 2008 Jan 23(1):CD000253. doi: 10.1002/14651858.CD000253.pub2.
2
Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration.
Arch Ophthalmol. 2002 Aug;120(8):1029-38. doi: 10.1001/archopht.120.8.1029.
3
Vitamin E supplementation and macular degeneration: randomised controlled trial.
BMJ. 2002 Jul 6;325(7354):11. doi: 10.1136/bmj.325.7354.11.
4
Ceramic photocell implants could restore sight.
Aerosp Am. 2002 Apr;40(4):18-9.
5
Intraocular retinal prosthesis.
Trans Am Ophthalmol Soc. 2001;99:271-300.
6
7
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
Arch Ophthalmol. 2001 Oct;119(10):1417-36. doi: 10.1001/archopht.119.10.1417.
8
9
10
Risk factors for age-related macular degeneration.
Prog Retin Eye Res. 2001 Mar;20(2):227-53. doi: 10.1016/s1350-9462(00)00023-9.
Zotero 插件